Labo Line Oy is a limited company based in Helsinki, registered in 1993. In the financial year ending 31.3.2025, revenue was 5,1 M€ and operating profit 434 t€; equity ratio 74.2 %. Its taxable income in 2024 was 253 t€ and its income taxes 52 t€. Public buyers bought 1,8 M€ from it in 2022–2026; the largest buyer is Luonnonvarakeskus (Maa- ja metsätalousministeriön hallinnonala). It has won 8 public contracts in EU procurement notices.
Financials
| Key figures | 31.3.2025 | 31.3.2024 | 31.3.2023 | 31.3.2022 | 31.3.2021 |
|---|---|---|---|---|---|
| Revenue | 5,1 M€ | 4,9 M€ | 5,8 M€ | 4,7 M€ | 4,1 M€ |
| Revenue change | 3,1 % | -14,0 % | 22,2 % | 14,7 % | – |
| EBITDA | 460 t€ | 288 t€ | 846 t€ | 504 t€ | 535 t€ |
| EBITDA % | 9,0 % | 5,8 % | 14,7 % | 10,7 % | 13,0 % |
| Operating profit | 434 t€ | 262 t€ | 817 t€ | 468 t€ | 491 t€ |
| Operating margin | 8,5 % | 5,3 % | 14,2 % | 9,9 % | 12,0 % |
| Net profit | 343 t€ | 200 t€ | 646 t€ | 370 t€ | 387 t€ |
| Personnel costs | 944 t€ | 1,1 M€ | 819 t€ | 725 t€ | 712 t€ |
| Equity ratio | 74,2 % | 76,2 % | 74,5 % | 68,1 % | 72,3 % |
| Quick ratio | 1,32 | 2,03 | 1,82 | 1,59 | 1,87 |
| Current ratio | 1,96 | 2,95 | 2,70 | 2,28 | 2,76 |
| Debt to revenue | 18,3 % | 16,0 % | 15,2 % | 20,5 % | 18,3 % |
| Return on equity | 12,8 % | 7,9 % | 25,4 % | 17,9 % | 19,8 % |
| Balance sheet total | 4,4 M€ | 3,3 M€ | 3,5 M€ | 3,0 M€ | 2,7 M€ |
| Equity | 2,7 M€ | 2,5 M€ | 2,5 M€ | 2,1 M€ | 2,0 M€ |
| Cash and bank | 557 t€ | 499 t€ | 465 t€ | 66 t€ | 428 t€ |
Balance sheet
Income statement and balance sheet
Income statement
| 31.3.2025 | 31.3.2024 | 31.3.2023 | 31.3.2022 | 31.3.2021 | |
|---|---|---|---|---|---|
| Turnover | 5,1 M€ | 4,9 M€ | 5,8 M€ | 4,7 M€ | 4,1 M€ |
| Other operating income | 47 t€ | 46 t€ | 54 t€ | 69 t€ | 51 t€ |
| Raw materials and services | -3,2 M€ | -3,1 M€ | -3,7 M€ | -3,2 M€ | -2,6 M€ |
| Personnel expenses | -944 t€ | -1,1 M€ | -819 t€ | -725 t€ | -712 t€ |
| Depreciations and reductions in value | -26 t€ | -25 t€ | -29 t€ | -37 t€ | -44 t€ |
| Other operating expenses | -514 t€ | -486 t€ | -459 t€ | -333 t€ | -290 t€ |
| Operating profit (loss) | 434 t€ | 262 t€ | 817 t€ | 468 t€ | 491 t€ |
| Financial income and expenses + (-) | -4 976 € | -12 t€ | -8 705 € | -4 994 € | -7 351 € |
| Profit (loss) before appropriations and taxes | 429 t€ | 251 t€ | 808 t€ | 463 t€ | 484 t€ |
| Income taxes | -86 t€ | -51 t€ | -162 t€ | -93 t€ | -97 t€ |
| Profit (loss) for the financial year | 343 t€ | 200 t€ | 646 t€ | 370 t€ | 387 t€ |
Balance sheet
| 31.3.2025 | 31.3.2024 | 31.3.2023 | 31.3.2022 | 31.3.2021 | |
|---|---|---|---|---|---|
| Non-current assets | 1,1 M€ | 1,1 M€ | 1,1 M€ | 1,0 M€ | 1,0 M€ |
| Stocks | 1,1 M€ | 706 t€ | 798 t€ | 604 t€ | 540 t€ |
| Receivables | 1,6 M€ | 1,1 M€ | 1,2 M€ | 1,3 M€ | 696 t€ |
| Cash in hand and at banks | 557 t€ | 499 t€ | 465 t€ | 66 t€ | 428 t€ |
| Current assets | 3,3 M€ | 2,3 M€ | 2,5 M€ | 2,0 M€ | 1,7 M€ |
| Assets | 4,4 M€ | 3,3 M€ | 3,5 M€ | 3,0 M€ | 2,7 M€ |
| Share capital or other similar capital | 3 000 € | 3 000 € | 3 000 € | 3 000 € | 3 000 € |
| Capital and reserves | 2,7 M€ | 2,5 M€ | 2,5 M€ | 2,1 M€ | 2,0 M€ |
| Long-term liabilities | 33 t€ | 25 t€ | 74 t€ | 92 t€ | 148 t€ |
| Short-term liabilities | 1,7 M€ | 768 t€ | 907 t€ | 874 t€ | 602 t€ |
| Liabilities | 1,7 M€ | 794 t€ | 981 t€ | 966 t€ | 750 t€ |
All financial statement items (57)
| 31.3.2025 | 31.3.2024 | 31.3.2023 | 31.3.2022 | 31.3.2021 | |
|---|---|---|---|---|---|
| Turnover | 5,1 M€ | 4,9 M€ | 5,8 M€ | 4,7 M€ | 4,1 M€ |
| Other operating income | 47 t€ | 46 t€ | 54 t€ | 69 t€ | 51 t€ |
| Raw materials and services | -3,2 M€ | -3,1 M€ | -3,7 M€ | -3,2 M€ | -2,6 M€ |
| Personnel expenses | -944 t€ | -1,1 M€ | -819 t€ | -725 t€ | -712 t€ |
| Depreciations and reductions in value | -26 t€ | -25 t€ | -29 t€ | -37 t€ | -44 t€ |
| Other operating expenses | -514 t€ | -486 t€ | -459 t€ | -333 t€ | -290 t€ |
| Operating profit (loss) | 434 t€ | 262 t€ | 817 t€ | 468 t€ | 491 t€ |
| Financial income and expenses + (-) | -4 976 € | -12 t€ | -8 705 € | -4 994 € | -7 351 € |
| Profit (loss) before appropriations and taxes | 429 t€ | 251 t€ | 808 t€ | 463 t€ | 484 t€ |
| Income taxes | -86 t€ | -51 t€ | -162 t€ | -93 t€ | -97 t€ |
| Profit (loss) for the financial year | 343 t€ | 200 t€ | 646 t€ | 370 t€ | 387 t€ |
| Non-current assets | 1,1 M€ | 1,1 M€ | 1,1 M€ | 1,0 M€ | 1,0 M€ |
| Stocks | 1,1 M€ | 706 t€ | 798 t€ | 604 t€ | 540 t€ |
| Receivables | 1,6 M€ | 1,1 M€ | 1,2 M€ | 1,3 M€ | 696 t€ |
| Cash in hand and at banks | 557 t€ | 499 t€ | 465 t€ | 66 t€ | 428 t€ |
| Current assets | 3,3 M€ | 2,3 M€ | 2,5 M€ | 2,0 M€ | 1,7 M€ |
| Assets | 4,4 M€ | 3,3 M€ | 3,5 M€ | 3,0 M€ | 2,7 M€ |
| Share capital or other similar capital | 3 000 € | 3 000 € | 3 000 € | 3 000 € | 3 000 € |
| Capital and reserves | 2,7 M€ | 2,5 M€ | 2,5 M€ | 2,1 M€ | 2,0 M€ |
| Long-term liabilities | 33 t€ | 25 t€ | 74 t€ | 92 t€ | 148 t€ |
| Short-term liabilities | 1,7 M€ | 768 t€ | 907 t€ | 874 t€ | 602 t€ |
| Liabilities | 1,7 M€ | 794 t€ | 981 t€ | 966 t€ | 750 t€ |
| Other current liabilities | 291 t€ | 280 t€ | 220 t€ | 376 t€ | 184 t€ |
| Investments | 1,0 M€ | 991 t€ | 971 t€ | 952 t€ | 935 t€ |
| Long-term receivables | 150 t€ | 70 t€ | 0 € | – | – |
| Short-term sales receivables | 1,4 M€ | 836 t€ | 1,2 M€ | 1,3 M€ | 672 t€ |
| Retained earnings | 2,3 M€ | 2,3 M€ | 1,9 M€ | 1,7 M€ | 1,6 M€ |
| Other social security expenses | -19 t€ | -21 t€ | -18 t€ | -19 t€ | -17 t€ |
| Advance payments and construction in progress | 20 t€ | 0 € | 20 t€ | 0 € | – |
| Other long-term receivables | 150 t€ | 70 t€ | 0 € | – | – |
| Other shares and similar rights of ownership | 843 t€ | 823 t€ | 803 t€ | 784 t€ | 768 t€ |
| Purchases during the financial year | -3,6 M€ | -2,9 M€ | -3,9 M€ | -3,2 M€ | -2,5 M€ |
| Short-term accounts payable | 377 t€ | 314 t€ | 396 t€ | 298 t€ | 194 t€ |
| Pension expenses | -149 t€ | -158 t€ | -135 t€ | -116 t€ | -105 t€ |
| Services purchased | -105 t€ | -80 t€ | -149 t€ | -79 t€ | -100 t€ |
| Tangible assets | 99 t€ | 75 t€ | 103 t€ | 81 t€ | 96 t€ |
| Profit (loss) for the period, equity | 343 t€ | 200 t€ | 646 t€ | 370 t€ | 387 t€ |
| Advance payments | – | – | – | 0 € | 210 t€ |
| Short-term liabilities to credit institutions | 24 t€ | 49 t€ | 53 t€ | 57 t€ | 65 t€ |
| Other intangible assets | – | – | – | 0 € | 8 541 € |
| Finished products | 1,1 M€ | 706 t€ | 798 t€ | 604 t€ | 330 t€ |
| Long-term liabilities to credit institutions | 33 t€ | 25 t€ | 74 t€ | 92 t€ | 148 t€ |
| Intangible assets | – | – | 0 € | 951 € | 10 t€ |
| Short-term advances received | 771 t€ | 0 € | 108 t€ | 0 € | – |
| Interest expenses and other financial expenses for non-Group companies | -4 984 € | -12 t€ | -8 758 € | -4 994 € | -7 351 € |
| Intangible rights | – | – | 0 € | 951 € | 1 901 € |
| Short-term loan receivables | – | – | 0 € | 672 € | 0 € |
| Inventory increase (+) or decrease (-) | 476 t€ | -194 t€ | 353 t€ | 28 t€ | -5 774 € |
| Machinery and equipment | 78 t€ | 75 t€ | 83 t€ | 81 t€ | 96 t€ |
| Other interest and financial income from non-group companies | 8 € | 0 € | 54 € | 0 € | 0 € |
| Wages and salaries | -775 t€ | -892 t€ | -666 t€ | -590 t€ | -590 t€ |
| Depreciations according to plan | -26 t€ | -25 t€ | -29 t€ | -37 t€ | -44 t€ |
| Short-term prepayments and accrued income | 87 t€ | 157 t€ | 25 t€ | 22 t€ | 23 t€ |
| Liabilities | 4,4 M€ | 3,3 M€ | 3,5 M€ | 3,0 M€ | 2,7 M€ |
| Short-term accrued expenses and deferred income | 210 t€ | 126 t€ | 130 t€ | 143 t€ | 160 t€ |
| Shares in participating interest company | 168 t€ | 168 t€ | 168 t€ | 168 t€ | 168 t€ |
| Short-term receivables | 1,5 M€ | 993 t€ | 1,2 M€ | 1,3 M€ | 696 t€ |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Labo Line Oy is in the upper half of the industry class wholesale of medical goods (201 companies with taxable income; median 133 t€).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.
Sales to public buyers
Largest buyers
Public contracts won
- Syväjääpakastimet 2026-2029 (2030-2031)Terveyden ja hyvinvoinnin laitos350 t€
- BiosuojakaapitHUS-yhtymä609 t€
- Biosafety cabinets and glove boxes (for new laboratory facility)Tampere University Foundation sr212 t€
- Laboratoriotason kylmälaitteiden hankinta uuteen Noodi-rakennukseenTampereen korkeakoulusäätiö sr323 t€
- Välinehuollon tarvikkeetTuomi Logistiikka Oy, Etelä-Pohjanmaan hyvinvointialue1,7 M€
- JÄLKI-ILMOITUS Autoklaavien ja olosuhdekaappien hankinta LuonnonvarakeskukselleLuonnonvarakeskus420 t€
Show all 8
- Olosuhdevalvontajärjestelmä Kuopion toimispisteeseenTerveyden ja hyvinvoinnin laitos122 t€
- TP27/25EU SyväjääpakastimetVarsinais-Suomen hyvinvointialue270 t€
Follow companies in your area
New companies, bankruptcies and changes of CEO and property manager in the areas and industries you choose, by email. 14-day free trial, cancel any time.
Try for free